Timely integration of palliative care. the reality check. a retrospective analysis
Supportive Care in Cancer · 2024
DOI: 10.1007/s00520-024-08721-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von F Adamidis und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine I, Division of Palliative Medicine, Medical University of Vienna, Vienna, Austria. feroniki.adamidis@meduniwien.ac.at. Hauptthemen laut MEDLINE: Palliative Care. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Vienna.
Themen: Palliativpflege
Abstract (Originalsprache)
Purpose
A large volume of literature suggests that timely integration of palliative care (PC) enhances the well-being, quality of life and satisfaction of patients and their families. It may also positively impact clinical outcomes and healthcare costs throughout the disease trajectory. Therefore, reviewing clinical practice to reflect real-life situations regarding timely PC integration is essential.
Methods
This study, conducted at the Vienna General Hospital between March 2016 and August 2022, retrospectively examined PC consultation (PCC) requests. It aimed to assess the timeliness of PC integration by analysing the duration between diagnosis and the first PCC request, as well as the interval between the first PCC request and death.
Results
This study included 895 PCCs. The median time from diagnosis to the first PCC was 16.6 (interquartile range (IQR): 3.9–48.4) months, while the median time from the first PCC to death was 17.2 (IQR: 6.1–50.7) days. The median time from diagnosis to first PCC was 10.4 months in females (confidence interval (CI): 6.0–14.8) compared to 10.6 months in males (CI: 8.1–13.1; p = 0.675). There were no gender disparities in the time from first PCC to death, with a median of 23.3 days (CI: 15.6–31.0) for females and 22.3 days (CI: 16.2–28.4) for males ( p = 0.93). Fifty percent of patients died between 5 and 47 days after the first PCC.
Conclusion
These findings highlight the discrepancy between the clinical perception of PC as end-of-life care and the existing literature, thereby emphasising the importance of timely PC integration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine I, Division of Palliative Medicine, Medical University of Vienna, Vienna, Austria. feroniki.adamidis@meduniwien.ac.at.
- Department of Medicine I, Division of Palliative Medicine, Medical University of Vienna, Vienna, Austria.
- Department of Internal Medicine II, Clinical Division of Palliative Medicine, University Hospital Krems, Krems an Der Donau, Austria.
- Karl Landsteiner University of Health Sciences, Krems an Der Donau, Austria.
- Department of Health Economics, Center for Public Health, Medical University of Vienna, 1090, Vienna, Austria.
- Department of Clinical and Health Psychology, Faculty of Psychology, University of Vienna, Vienna, Austria.
Förderung
- Medical University of Vienna
Zitieren
APA
Adamidis, F., Baumgartner, N. S., Kitta, A., Kum, L., Ecker, F., Bär, J., Marosi, C., Kreye, G., Fischer, C., Zeilinger, E. L., Paschen, C., Wenzel, C., & Masel, E. K. (2024). Timely integration of palliative care. the reality check. a retrospective analysis. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-08721-x
Vancouver
Adamidis F, Baumgartner NS, Kitta A, Kum L, Ecker F, Bär J, et al. Timely integration of palliative care. the reality check. a retrospective analysis. Supportive Care in Cancer. 2024. doi:10.1007/s00520-024-08721-x
BibTeX
@article{Adamidis2024,
author = {Adamidis, F and Baumgartner, N S and Kitta, A and Kum, L and Ecker, F and Bär, J and Marosi, C and Kreye, G and Fischer, C and Zeilinger, E L and Paschen, C and Wenzel, C and Masel, E K},
title = {Timely integration of palliative care. the reality check. a retrospective analysis},
journal = {Supportive Care in Cancer},
year = {2024},
doi = {10.1007/s00520-024-08721-x}
}
EUVIMED